ER expression in our study showed a peak in group C (patients older than 60 y/o) while PR gradually reduces after the 6th decade of life, supporting the concept that estrogen plays a role in developing Luminal A and Luminal B cancers (typically ER+ and PR +/−). This evidence concerns the gene PGR and cancer.